Synopsys Announces Executive and Board Changes

Ticker: SNPS · Form: 8-K · Filed: 2025-11-04T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, board-changes, compensation

TL;DR

Synopsys shakes up exec team and board, effective Nov 4.

AI Summary

Synopsys Inc. announced on November 1, 2025, changes in its executive team and board of directors. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. These changes are effective as of November 4, 2025.

Why It Matters

Changes in executive leadership and board composition can signal shifts in company strategy, governance, or future performance.

Risk Assessment

Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and leadership stability.

Key Players & Entities

FAQ

What specific roles have been affected by the executive and director changes?

The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for certain officers, but does not specify the exact roles affected in this summary.

When are these changes officially effective?

The changes are effective as of November 4, 2025.

What is the primary reason cited for these changes?

The filing does not provide a specific reason for the changes, only that they pertain to departures, elections, and compensatory arrangements.

Does this filing include details on new executive compensation packages?

Yes, the filing mentions updates to 'Compensatory Arrangements of Certain Officers'.

What is Synopsys Inc.'s principal executive office address?

Synopsys Inc.'s principal executive offices are located at 675 Almanor Ave, Sunnyvale, California 94085.

From the Filing

0001193125-25-263692.txt : 20251104 0001193125-25-263692.hdr.sgml : 20251104 20251104091540 ACCESSION NUMBER: 0001193125-25-263692 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251101 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20251104 DATE AS OF CHANGE: 20251104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOPSYS INC CENTRAL INDEX KEY: 0000883241 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] ORGANIZATION NAME: 06 Technology EIN: 561546236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19807 FILM NUMBER: 251446793 BUSINESS ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 6505845000 MAIL ADDRESS: STREET 1: 675 ALMANOR AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 8-K 1 d89167d8k.htm 8-K 8-K SYNOPSYS INC false 0000883241 0000883241 2025-11-01 2025-11-01     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2025     SYNOPSYS, INC. (Exact Name of Registrant as Specified in its Charter)       Delaware   000-19807   56-1546236 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification Number)   675 Almanor Ave Sunnyvale , California 94085 (Address of Principal Executive Offices) (Zip Code) (650) 584-5000 (Registrant’s telephone number, including area code) N/A (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (par value of $0.01 per share)   SNPS   Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging Growth Company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 4, 2025, Synopsys, Inc. (“ Synopsys ”) announced that Rick Mahoney will no longer serve as Synopsys’ Chief Revenue Officer, effective immediately. Synopsys is in advanced stages of its search and expects to announce a replacement shortly.   Item 7.01 Regulation FD Disclosure. Synopsys reaffirms its financial targets for the fourth quarter and full fisc

View on Read The Filing